Glecaprevir/pibrentasvir in chronic HCV: An integrated analysis of participants on concomitant opioids, antipsychotics and cardiovascular medications

Conference Reports for NATAP

EASL - European Association
for the Study of the Liver
May 7-10, 2025
Amsterdam the Netherlands


Glecaprevir/pibrentasvir in chronic HCV: An integrated analysis of participants on concomitant opioids, antipsychotics and cardiovascular medications

	EASL May 7-10, 2025 Amsterdam, Netherlands